🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 23 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/01/2017 40,49 40,78 39,51 40,12 +0,00% 3,14% 797.600
24/01/2017 38,72 40,30 38,43 40,12 +3,30% 4,83% 877.400
23/01/2017 41,27 41,57 38,77 38,84 -5,89% 6,78% 1.083.500
20/01/2017 41,60 41,89 40,80 41,27 -0,84% 2,62% 768.900
19/01/2017 41,93 42,15 40,36 41,62 -1,00% 4,27% 1.218.100
18/01/2017 39,50 43,44 38,84 42,04 +4,66% 11,65% 3.426.500
17/01/2017 41,94 42,81 39,87 40,17 -4,92% 7,01% 1.784.700
13/01/2017 41,17 43,57 41,09 42,25 +2,77% 6,02% 1.457.000
12/01/2017 40,27 41,92 40,07 41,11 +1,16% 4,59% 1.045.500
11/01/2017 42,41 42,57 40,00 40,64 -4,62% 6,06% 1.621.200
10/01/2017 45,25 45,89 42,48 42,61 -5,31% 7,54% 1.667.000
09/01/2017 44,50 45,29 44,05 45,00 +2,18% 2,79% 1.457.000
06/01/2017 44,00 45,20 42,13 44,04 +6,43% 6,98% 3.101.400
05/01/2017 41,05 41,74 41,02 41,38 +0,24% 1,75% 1.073.600
04/01/2017 38,80 41,94 38,61 41,28 +6,78% 8,58% 1.568.700
03/01/2017 38,79 39,80 38,38 38,66 -0,10% 3,66% 937.300
30/12/2016 38,01 38,72 37,56 38,70 +2,11% 3,05% 835.100
29/12/2016 37,91 38,33 37,35 37,90 -0,24% 2,59% 740.800
28/12/2016 38,37 38,80 37,80 37,99 -0,84% 2,61% 687.200
27/12/2016 39,79 39,79 37,90 38,31 -3,38% 4,75% 1.298.200
23/12/2016 39,13 39,81 38,81 39,65 +1,56% 2,56% 870.100
22/12/2016 40,24 40,78 38,47 39,04 -2,86% 5,74% 1.637.000
21/12/2016 41,31 41,71 40,08 40,19 -2,81% 3,95% 775.100
20/12/2016 40,64 41,52 40,51 41,35 +1,85% 2,49% 696.200
19/12/2016 42,35 42,66 40,27 40,60 -4,36% 5,64% 823.900
16/12/2016 43,55 44,26 42,13 42,45 -3,21% 4,89% 1.129.900
15/12/2016 43,50 43,89 42,70 43,86 +1,46% 2,74% 997.700
14/12/2016 43,12 43,65 42,70 43,23 -0,39% 2,20% 669.000
13/12/2016 42,14 43,53 42,06 43,40 +3,31% 3,49% 1.275.100
12/12/2016 41,11 42,18 41,01 42,01 +0,84% 2,85% 675.900